Skip to search formSkip to main contentSkip to account menu

Indinavir:ACnc:Pt:Ser/Plas:Qn

Known as: Indinavir:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif, Indinavir:SçKons:Zml?:Ser/Plaz:Kant, Indinavir:????:????:??/??:?? 
National Institutes of Health

Related topics

Related topics

4 relations
ACncIndinavirPlasSerum

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
METHOD DEVELOPMENT AND VALIDATION OF INDINAVIR SULPHATE CAPSULES BY RP-HPLC METHOD
A validated RP-HPLC method has been developed for the determination of Indinavir sulphate capsule dosage form. This method is… 
2013
2013
Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
2006
2006
Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals.
Indinavir is a potent HIV-1 protease inhibitor included in current antiretroviral therapeutic regimens. It is associated with… 
2005
2005
Comparable pharmacokinetics of generic indinavir (Inhibisam) versus brand indinavir (Crixivan) when boosted with ritonavir.
2004
2004
The ICH guidance in practice: stress degradation studies on indinavir sulphate and development of a validated specific stability-indicating HPTLC assay method.
2003
2003
The Preparedness of national secondary school teachers in Nairobi Province to implement HIV/AIDS Education curriculum
xv 
2002
2002
A Once-Daily Haart Regimen Containing Indinavir + Ritonavir plus One Or Two Nucleoside Reverse Transcriptase Inhibitors (Pipo Study)
Introduction There is an increased interest in developing once-daily regimens for the treatment of HIV-infected patients. A Phase… 
2002
2002
CRIXIVAN ® ( INDINAVIR SULFATE ) CAPSULES
  • 2002
  • Corpus ID: 53004650
DESCRIPTION CRIXIVAN (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease. CRIXIVAN Capsules… 
Review
2002
Review
2002
[Renal lithiasis due to indinavir].
Indinavir sulphate is a protease inhibitor that has been found to be extremely effective in increasing CD4+ cell counts and in… 
Review
2001
Review
2001
Combination Therapy with Indinavir, Ritonavir, and Delavirdine and Nucleoside Reverse Transcriptase Inhibitors in Patients with HIV/AIDS Who Have Failed Multiple Antiretroviral Combinations
Abstract Purpose: Ritonavir (RTV) and delavirdine (DLV) are inhibitors of cytochrome P450 (CYP) 3A4, the specific CYP that… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)